Aerie pharmaceuticals, inc. (AERI)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash flows from operating activities
Net loss

-49,129

-55,064

-49,402

-47,164

-47,951

-51,458

-85,388

-55,024

-40,699

-58,513

-32,372

-28,433

-25,787

-29,322

-23,814

-23,219

-22,704

-20,377

-17,961

-18,786

-17,239

-16,501

-13,147

-11,814

-6,671

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation

1,591

1,490

1,551

1,495

564

670

649

594

487

484

316

309

291

268

245

234

223

150

42

36

24

23

19

16

15

Amortization and accretion

6,585

6,641

1,284

2,946

2,105

813

633

222

-22

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and fees

-

-

-

-

-

-

-

-

-

-

77

77

76

76

76

76

75

73

77

78

77

77

0

0

0

Amortization and accretion of premium or discount on investments, net

-

-

-

-

-

-

-

-

-

-

8

-8

-52

-122

-128

-128

-147

-131

-134

-142

-163

-169

-90

-101

-56

Stock-based compensation

10,529

11,172

10,606

10,695

12,620

9,713

9,978

10,318

8,719

8,006

6,557

6,665

4,850

5,280

4,099

3,881

3,534

3,412

3,316

3,476

2,741

2,482

2,392

2,382

1,922

Other non-cash

39

19

97

-31

186

63

42

315

-150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized foreign exchange (gain) loss

-

-

-

-

-

-

-

-

-

-

-157

-365

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities
Accounts receivable, net

4,587

5,076

7,627

10,893

12,043

754

836

1,125

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

-1,048

6,177

4,066

47

-33

4,390

-247

4,577

969

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid, current and other assets

2,410

-571

-857

2,181

1,391

1,746

483

-3,066

1,628

3,957

47

-338

-1,427

936

1,707

-288

-503

602

165

-132

205

697

-272

265

27

Accounts payable, accrued expenses and other current liabilities

-3,952

10,190

10,009

9,834

-1,267

15,659

7,920

9,877

-6,873

2,906

4,043

-261

-5,763

5,666

-189

-1,868

-1,130

2,978

2,628

-1,365

1,144

2,562

903

1,156

208

Operating lease liabilities

1,458

-

1,312

1,186

1,123

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-

6

6

-12

-

-

0

0

Net cash used in operating activities

-41,822

-27,124

-38,197

-36,470

-48,639

-31,514

-43,263

-36,964

-40,835

-26,150

-21,277

-20,932

-24,854

-18,846

-21,162

-20,474

-19,358

-14,235

-11,923

-16,281

-13,307

-11,334

-9,471

-8,424

-4,497

Cash flows from investing activities
Purchase of available-for-sale investments

15,834

68,186

97,268

0

0

0

0

0

56,195

3,273

46,790

8,866

45,561

15,221

720

5,963

13,265

20,312

12,585

5,787

8,188

60,783

2,741

2,507

29,345

Proceeds from sales and maturities of investments

50,557

0

0

0

0

1,000

14,470

69,052

23,775

39,457

23,895

11,941

12,860

-

-

-

-

-

-

-

-

-

-

-

-

Maturity of available-for-sale investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,036

-

16,725

9,260

14,828

10,079

7,675

2,985

0

Purchase of property, plant and equipment

1,240

2,047

793

2,179

4,939

1,909

6,372

13,906

9,126

8,897

4,479

1,690

904

3,685

933

124

335

1,425

803

513

539

35

87

30

29

Net cash provided by (used in) investing activities

33,483

-78,068

-98,061

-2,179

-4,939

-909

8,098

55,146

-41,546

16,787

-27,374

1,385

-33,605

4,085

8,887

2,692

2,436

-5,015

5,087

3,209

6,101

-50,739

6,347

448

-29,374

Cash flows from financing activities
Proceeds from Issuance of Common Stock

-

-

-

-

-

0

0

0

135,972

12,169

0

122,046

0

-

-

-

-

3,351

11,674

426

35,000

0

0

0

0

Payments related to issuance of stock for stock-based compensation arrangements, net

-1,422

1,281

371

-369

-599

697

1,240

3,113

-1,420

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

1,157

112

0

-

-

-

-

Proceeds from exercise of stock purchase rights

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

252

-

26

0

70

0

54

0

65

Tax withholdings related to restricted stock awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

-

0

0

0

-

-

-

-

Proceeds from exercise of warrants

0

386

0

0

375

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds related to issuance of stock for stock-based compensation arrangements, net

-

-

-

-

-

-

-

-

-

685

79

617

48

-

-

-

-

-

-

-

-

-

-

-

-

Other financing

0

0

-97

-91

-148

-148

-148

-148

-239

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-1,422

430

275,597

-856

-372

287

-529

2,965

134,313

12,854

79

122,663

48

768

165,694

2,035

128

3,364

12,866

538

35,070

-1,225

124,132

9

65

Net change in cash and cash equivalents

-9,761

-104,762

139,339

-39,505

-53,950

-32,136

-35,694

21,147

51,932

3,491

-48,572

103,116

-58,411

-13,993

153,419

-15,747

-16,794

-15,886

6,030

-12,534

27,864

-63,298

121,008

-7,967

-33,806

Supplemental disclosures
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

551

545

545

551

551

545

539

551

0

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

0

1,789

0

131

469

0

-

-

-

-

Non-cash investing and financing activities
Build-to-suit lease transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Interest capitalized during construction period for build-to-suit lease transaction

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Purchase of property, plant and equipment

254

-618

472

-691

1,608

460

-2,102

-6,245

11,413

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-